Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1978 Jan;31(1):89–92. doi: 10.1136/jcp.31.1.89

Dysfibrinogenaemia and liver cell growth.

R D Barr, M Allardyce, P W Brunt, J L McPhie
PMCID: PMC476725  PMID: 627621

Abstract

From the evidence presented, it is proposed that 'dysfibrinogenaemia' represents the production of normal fetal fibrinogen by rapidly proliferating liver cells in both regenerating and neoplastic tissue. Prolongation of the reptilase clotting time, which was formerly believed to reflect dysfibrinogenaemia, may be rather the result of hepatocytic death.

Full text

PDF
90

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aiach M., Rogé J., Busy M. F., Durand H., Guéroult N., Chanrion C., Leclerc M., Justin-Besançon L. Dysfibrinogénémies acquises et affections hépatiques. A propos de 30 observations. Sem Hop. 1973 Jan 14;49(3):183–197. [PubMed] [Google Scholar]
  2. Alter B. P., Rappeport J. M., Huisman T. H., Schroeder W. A., Nathan D. G. Fetal erythropoiesis following bone marrow transplantation. Blood. 1976 Dec;48(6):843–853. [PubMed] [Google Scholar]
  3. Barr R. D., Ouna N., Simpson J. G., Bagshawe A. F. Dysfibrinogenaemia and primary hepato-cellular carcinoma. Q J Med. 1976 Oct;45(180):647–659. [PubMed] [Google Scholar]
  4. Bloomer J. R., Waldmann T. A., McIntire K. R., Klatskin G. alpha-fetoprotein in noneoplastic hepatic disorders. JAMA. 1975 Jul 7;233(1):38–41. doi: 10.1001/jama.233.1.38. [DOI] [PubMed] [Google Scholar]
  5. FAHEY J. L., MCKELVEY E. M. QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES. J Immunol. 1965 Jan;94:84–90. [PubMed] [Google Scholar]
  6. Fishman W. H. Activation of developmental genes in neoplastic transformation. Cancer Res. 1976 Sep;36(9 Pt 2):3423–3428. [PubMed] [Google Scholar]
  7. Gralnick H. R., Finlayson J. S. Congenital dysfibrinogenemias. Ann Intern Med. 1972 Sep;77(3):471–473. doi: 10.7326/0003-4819-77-3-471. [DOI] [PubMed] [Google Scholar]
  8. Gralnick H. R., Givelber H. M., Shainoff J. R., Finlayson J. S. Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release. J Clin Invest. 1971 Sep;50(9):1819–1830. doi: 10.1172/JCI106673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Green G., Thomson J. M., Dymock I. W., Poller L. Abnormal fibrin polymerization in liver disease. Br J Haematol. 1976 Nov;34(3):427–439. doi: 10.1111/j.1365-2141.1976.tb03589.x. [DOI] [PubMed] [Google Scholar]
  10. Jerry L. M., Lewis M. G., Rowden G., Sullivan A. K., Pitzele R., Law T. Fetal antigens in nonneoplastic conditions. Cancer Res. 1976 Sep;36(9 Pt 2):3446–3452. [PubMed] [Google Scholar]
  11. Kang K. Y., Higashino K., Takahashi Y., Hashinotsume M., Yamamura Y. -Fetoprotein in infantile diseases. Clin Chim Acta. 1972 Nov;42(1):175–180. doi: 10.1016/0009-8981(72)90392-0. [DOI] [PubMed] [Google Scholar]
  12. Lane D. A., Scully M. F., Thomas D. P., Kakkar V. V., Woolf I. L., Williams R. Acquired dysfibrinogenaemia in acute and chronic liver disease. Br J Haematol. 1977 Feb;35(2):301–308. doi: 10.1111/j.1365-2141.1977.tb00586.x. [DOI] [PubMed] [Google Scholar]
  13. Maurer H. S., Vida L. N., Honig G. R. Similarities of the erythrocytes in juvenile chronic myelogenous leukemia to fetal erythrocytes. Blood. 1972 Jun;39(6):778–784. [PubMed] [Google Scholar]
  14. Millar H. R., Simpson J. G., Stalker A. L. An evaluation of the heat precipitation method for plasma fibrinogen estimation. J Clin Pathol. 1971 Dec;24(9):827–830. doi: 10.1136/jcp.24.9.827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ogston C. M., Ogston D. Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease. J Clin Pathol. 1966 Jul;19(4):352–356. doi: 10.1136/jcp.19.4.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. POPPER H. Liver disease-morphologic considerations. Am J Med. 1954 Jan;16(1):98–117. doi: 10.1016/0002-9343(54)90326-5. [DOI] [PubMed] [Google Scholar]
  17. STRAUB P. W. A study of fibrinogen production by human liver slices in vitro by an immunoprecipitin method. J Clin Invest. 1963 Jan;42:130–136. doi: 10.1172/JCI104690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sell S., Wepsic H. T., Nickel R., Nichols M. Rat alpha1 fetoprotein. IV. Effect of growth and surgical removal of Morris hepatoma 7777 on the serum alpha1F concentration of Buffalo rats. J Natl Cancer Inst. 1974 Jan;52(1):133–137. doi: 10.1093/jnci/52.1.133. [DOI] [PubMed] [Google Scholar]
  19. Verhaeghe R., van Damme B., Molla A., Vermylen J. Dysfibrinogenaemia associated with primary hepatoma. Scand J Haematol. 1972;9(5):451–458. doi: 10.1111/j.1600-0609.1972.tb00968.x. [DOI] [PubMed] [Google Scholar]
  20. Zeltzer P. M., Neerhout R. C., Fonkalsrud E. W., Stiehm E. R. Differentiation between neonatal hepatitis and biliary atresia by measuring serum-alpha-fetoprotein. Lancet. 1974 Mar 9;1(7854):373–375. doi: 10.1016/s0140-6736(74)93146-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES